Pure Global

CryoLab - Cryogenic spray, cutaneous - ARTG 380650

Access comprehensive regulatory information for CryoLab - Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 380650 and sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by CryoConcepts LP in United States of America. The device registration started on December 12, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
ARTG 380650
Class IIa
CryoLab - Cryogenic spray, cutaneous
ARTG ID: 380650
Good Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia - CryoLab - Cryogenic spray, cutaneous
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

This device is intended for the surgical destruction of target tissue by applying cryogenic gases at extreme low temperatures. Below are examples of the types of lesions that can be treated: Molluscum Contagiosum Skin Tags Actinic Keratosis Lentigo Verruca Plana Verruca Vulgaris Verruca Plantaris Genital Lesions Seborrheic Keratosis

Device Classification
Risk Class
Class IIa
Product Type
Medical device system
ARTG Category
General
Registration Information
ARTG ID
380650
Start Date
December 12, 2021
Effective Date
December 12, 2021
Manufacturer
Country
United States of America
Address
1100 Conroy Place, Easton, PA, 18040